July 14, 2014 1:26 AM ET

Biotechnology

Company Overview of Tapestry Pharmaceuticals, Inc.

Executive Profile

Mitchell A. Avery Ph.D.

Member of the Chemistry Advisory Board, Tapestry Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. Mitchell A. Avery Ph.D. has been Member of Chemistry Advisory Board for NaPro BioTherapeutics Inc. since April 2004. Dr. Avery serves as Interim Chair and Professor at the University of Mississippi's Department of Medicinal Chemistry. He also holds positions on the Editorial Advisory Board of Current Medicinal Chemistry and the Brazilian Journal of Pharmaceutical Sciences. Dr. Avery's research focuses on the discovery and development of anti-infective agents. He ...

Corporate Headquarters

4840 Pearl East Circle
Boulder, Colorado 80301-2408

United States

Phone: 303-516-8500
Fax: 303-530-1296

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
University of California, Santa Cruz

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tapestry Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.